Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)

NCT00147394 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Child Development Disorders, Pervasive

Interventions

DRUG: Risperidone

Sponsor

Children's Hospital Medical Center, Cincinnati